Trademark: 90460424
Status Date
Thursday, October 12, 2023
Filing Date
Tuesday, January 12, 2021
Published for Opposition
Tuesday, August 31, 2021
5 Pharmaceutical preparations for the treatment of psychiatric and neurodegenerative diseases including schizophrenia, depression, major depressive disorder, treatment resistant depression, bipolar depression, bipolar disorder,mitigation of weight gain, metabolic diseases and dyslipidemia
Oct 14, 2023
Notice Of Approval Of Extension Request E-Mailed
Oct 12, 2023
Sou Extension 4 Granted
Oct 12, 2023
Sou Extension 4 Filed
Oct 12, 2023
Sou Teas Extension Received
Mar 30, 2023
Notice Of Approval Of Extension Request E-Mailed
Mar 28, 2023
Sou Extension 3 Granted
Mar 28, 2023
Sou Extension 3 Filed
Mar 28, 2023
Sou Teas Extension Received
Oct 12, 2022
Notice Of Approval Of Extension Request E-Mailed
Oct 10, 2022
Sou Extension 2 Granted
Oct 10, 2022
Sou Extension 2 Filed
Oct 10, 2022
Sou Teas Extension Received
Apr 7, 2022
Notice Of Approval Of Extension Request E-Mailed
Apr 5, 2022
Sou Extension 1 Granted
Apr 5, 2022
Sou Extension 1 Filed
Apr 5, 2022
Sou Teas Extension Received
Oct 26, 2021
Noa E-Mailed - Sou Required From Applicant
Aug 31, 2021
Official Gazette Publication Confirmation E-Mailed
Aug 31, 2021
Published For Opposition
Aug 11, 2021
Notification Of Notice Of Publication E-Mailed
Jul 23, 2021
Approved For Pub - Principal Register
Jul 22, 2021
Assigned To Examiner
Apr 12, 2021
New Application Office Supplied Data Entered
Jan 15, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
